Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks
GT Jurgens, K Lackner
doi: https://doi.org/10.1101/2021.02.28.21252638
GT Jurgens
unaffiliated

Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Posted March 03, 2021.
Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks
GT Jurgens, K Lackner
medRxiv 2021.02.28.21252638; doi: https://doi.org/10.1101/2021.02.28.21252638
Subject Area
Subject Areas
- Addiction Medicine (227)
- Allergy and Immunology (500)
- Anesthesia (110)
- Cardiovascular Medicine (1226)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (9992)
- Gastroenterology (496)
- Genetic and Genomic Medicine (2433)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1633)
- Health Policy (750)
- Hematology (247)
- HIV/AIDS (529)
- Medical Education (251)
- Medical Ethics (73)
- Nephrology (267)
- Neurology (2268)
- Nursing (139)
- Nutrition (349)
- Oncology (1242)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (154)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (727)
- Primary Care Research (280)
- Public and Global Health (4816)
- Radiology and Imaging (833)
- Respiratory Medicine (650)
- Rheumatology (283)
- Sports Medicine (224)
- Surgery (266)
- Toxicology (44)
- Transplantation (123)
- Urology (99)